Mentice AB: Business Overview, Financials & Competitive Analysis
Mentice AB scores 7/10 on the AskCyborg Cyborg Score (Strong). Market-leading medical simulation provider with recurring revenue from global MedTech customers, strong profitability, and strategic portfolio expansion through acquisitions. Mentice holds a dominant market position in a specialized but growing medical simulation sector with strong financial momentum and strategic acquisitions. The company is profitable with record EBITDA and consistent customer.
What is Mentice AB's industry? Mentice AB (mentice.com) operates in Medical Device Simulation / Healthcare Education Technology. AskCyborg classifies Mentice AB under Medical Device Simulation / Healthcare Education Technology in its company registry.
Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Their solutions help healthcare professionals acquire, retain, and enhance their procedural skills, and are scienti...
Cyborg Score thesis
Market-leading medical simulation provider with recurring revenue from global MedTech customers, strong profitability, and...
Read the full analyst-debate transcript →Get the Latest Mentice AB Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeMentice AB Overview
Pro stress-test →Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Their solutions help healthcare professionals acquire, retain, and enhance their procedural skills, and are scientifically validated and specifically developed for healthcare providers and the medical device industry. The company addresses a critical need in medical training by providing virtual and physical simulation platforms that improve clinical outcomes while reducing procedural risks.
Strategic Profile
Pro stress-test →Mentice consolidates its position as the leading provider of virtual, physical and decision-support simulation solutions for image-guided interventional therapies, with acquired capabilities adding solutions for neurovascular and structural heart simulation plus patient-specific anatomy printing. The company achieved record net sales over 100 MSEK and EBITDA of 24.5 MSEK in recent results. The company is expanding strategically through acquisitions and partnerships to build a comprehensive simulation ecosystem for interventional medicine.
Competitive Landscape
Pro stress-test →Mentice is positioned as the world leader in simulation solutions for endovascular therapies. The company competes in the medical simulation space against providers of physical models and virtual reality training platforms. Key competitive advantages include scientific validation, integration of multiple simulation modalities (virtual, physical, decision-support), and deep relationships with major medical device manufacturers and healthcare systems.
Industry Context
Mentice AB operates in Medical Device Simulation / Healthcare Education Technology.
Key facts
Founded: 2000 · Headquarters: Gothenburg, Sweden · Revenue: 100+ MSEK (2024)